Free Trial

Fortrea Q2 2024 Earnings Report

Fortrea logo
$14.88 -0.73 (-4.68%)
As of 02/21/2025 04:00 PM Eastern

Fortrea EPS Results

Actual EPS
-$0.03
Consensus EPS
$0.07
Beat/Miss
Missed by -$0.10
One Year Ago EPS
$0.52

Fortrea Revenue Results

Actual Revenue
$662.40 million
Expected Revenue
$689.08 million
Beat/Miss
Missed by -$26.68 million
YoY Revenue Growth
-8.60%

Fortrea Announcement Details

Quarter
Q2 2024
Time
Before Market Opens

FTRE Upcoming Earnings

Fortrea will be holding an earnings conference call on Monday, March 3 at 9:00 AM Eastern. Interested parties can register for or listen to the call.

Conference Call Resources

Fortrea Earnings Headlines

Fortrea Holdings Inc. Appoints New Independent Director
1 Healthcare Stock to Hold Forever and 2 to Ignore
Collect $7k per month from Tesla’s SECRET dividend
There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?
Fortrea to Add Erin L. Russell to Board of Directors
Fortrea partners with Society for Clinical Research Sites
See More Fortrea Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Fortrea? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fortrea and other key companies, straight to your email.

About Fortrea

Fortrea (NASDAQ:FTRE), a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

View Fortrea Profile

More Earnings Resources from MarketBeat